ABSTRACT
El síndrome de neoplasia endocrina múltiple 2B (MEN 2B) es una entidad poco frecuente, que se caracteriza por la presencia de carcinoma medular de tiroides (CMT) en un 100% de los casos. El fenotipo de este síndrome incluye rasgos marfanoides y neuromas mucocutáneos. Describimos el caso de un paciente con un síndrome MEN 2B, al que se le diagnostica un cáncer medular de tiroides a partir del hallazgo de metástasis pulmonares y analizamos el papel del DMSA-V y de los nuevos sistemas híbridos SPECT-TAC en el estudio de extensión y seguimiento del CMT(AU)
Multiple endocrine neoplasia syndrome, type 2B (MEN 2B), is a rare entity characterized by the presence of medullary thyroid cancer in 100% of the cases. The phenotype of this syndrome consists in the presence of marfanoid features and mucocutaneous neuromas. We describe the case of a male patient with MEN 2B syndrome who was diagnosed with medullary thyroid cancer after lung metastases was found. We analyze the role of DMSA-V and the new hybrid SPECT-CT scan systems in the extension study and monitoring of medullary thyroid cancer(AU)
Subject(s)
Humans , Male , Adult , Tomography, Emission-Computed, Single-Photon/instrumentation , Tomography, Emission-Computed, Single-Photon/methods , Technetium Tc 99m Exametazime , Technetium Tc 99m Dimercaptosuccinic Acid , Thyroid Neoplasms , Thyroidectomy/methods , Thyroidectomy , Octreotide/therapeutic use , Tomography, Emission-Computed, Single-Photon/trends , Tomography, Emission-Computed, Single-Photon , Technetium Tc 99m Dimercaptosuccinic Acid/metabolism , Technetium Tc 99m Dimercaptosuccinic Acid/pharmacokinetics , Multiple Endocrine Neoplasia Type 2a/complications , Multiple Endocrine Neoplasia Type 2a/diagnosisABSTRACT
No disponible
